Coordinator

Prof. Josep M Llovet, M.D., Ph.D.

Project coordinator and leader of:
Project management and coordination (WP9);
Tissue and Data management (WP1);
Identifying tumor-host interactions in treated patients and identifying biomarkers (WP5);
Ensuring social impact and viability within and beyond the grant period (WP11).

Partners

Prof. Helen Reeves, M.D., Ph.D.

Leading the evaluation of clinical/molecular features to identify determinant of liver cancer onset and progression (WP2)

Prof. Quentin M Anstee, M.D., Ph.D.

Participating in the evaluation of clinical/molecular features to identify determinant of liver cancer onset and progression (WP2)

Prof. Jessica Zucman-Rossi, M.D., Ph.D.

Leading the single-cell and spatial transcriptomic profiling and genomic characterization of liver cancer (WP3)

Prof. Manel Esteller, M.D., Ph.D.

Leading the single-cell and spatial transcriptomic profiling and genomic characterization of liver cancer (WP3)

Prof. Eran Elinav, M.D., Ph.D.

Leading the characterization of the intratumoral microbiome landscape in liver cancer patients (WP4)

Georg Zeller, Ph.D.

Leading the characterization of the intratumoral microbiome landscape in liver cancer patients (WP4)

Carolina Armengol, Ph.D.

Leading the identification of tumor-host interactions in treated patients and identifying biomarkers (WP5)

Prof. Manfred Claassen, Ph.D.

Leading the development of an AI-based tool predicting treatment outcome using high-resolution histopathological images (WP6)

Prof. Mathias Heikenwälder, Ph.D.

Leading the development of a preclinical drug-testing platform and proposing new therapeutic strategies to overcome therapy resistances (WP7)

Prof. Sven Nahnsen, Ph.D.

Leading the Data Management and data integration in existing research infrastructures (WP8)

Jens Puschhof, Ph.D.

Leading the development of a preclinical drug-testing platform and proposing new therapeutic strategies to overcome therapy resistances (WP7)

Paola Cesaroni

Leading the dissemination, communication, exploitation of THRIVE results and liaising with EU-funded initiatives (WP10)

Mr. Marko Korenjak

Ensuring social impact and viability within and beyond the grant period (WP11)

Participating in the dissemination, communication, exploitation of THRIVE results and liaising with EU-funded initiatives (WP10)

Contact

August Pi i Sunyer Biomedical Research Institute (IDIBAPS)
08036 Barcelona

E-mail:
info@thrive-liver-cancer.eu

Project Info

Duration
December 2023 – December 2028

Programme
Horizon Europe
HORIZON-MISS-2023- CANCER-01-01

Reference
ID 101136622

Follow us

Other EU cluster projects

Privacy Preference Center